All Stories

  1. Comparative Evaluation of A Partial Dopamine Agonist with A Preferential D2 and D3 Receptor Antagonist on Ethanol Induced Conditioned Place Preference in Mice
  2. Serotonergic mechanisms in the 6-Hz psychomotor seizures in mice
  3. Review of the Literature Examining the Association of Serum Uric Acid with Osteoporosis and Mechanistic Insights into Its Effect on Bone Metabolism
  4. Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2
  5. The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats
  6. Aromatase inhibition by letrozole attenuates kainic acid-induced seizures but not neurotoxicity in mice
  7. Prevalence of osteoporosis and osteopenia in an apparently healthy Indian population - a cross-sectional retrospective study
  8. A Cross-Sectional Study to Assess the Modulation of Wnt Inhibitors following Anti-Epileptic Drug Therapy and their Correlation with Vitamin D and Receptor Activator of Nuclear Factor κ B Ligand in Indian Women with Epilepsy
  9. Animal models of status epilepticus and temporal lobe epilepsy: a narrative review
  10. Bisphosphonates: Future perspective for neurological disorders
  11. Effect of escitalopram and carbidopa on bone markers in Wistar rats: a preliminary experimental study
  12. Raised serum uric acid is associated with higher bone mineral density in a cross-sectional study of a healthy Indian population
  13. Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
  14. Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs
  15. Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms
  16. A review on therapeutic potentials of Trigonella foenum graecum (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential
  17. Data of aromatase inhibitors alone and in combination with raloxifene on microarchitecture of lumbar vertebrae and strength test in femoral diaphysis of VCD treated ovotoxic mice
  18. Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice
  19. Innovative Targets For Asthma And COPD: Exploring The Existing And Screening The New!!
  20. Augmentation of antidepressant effects of venlafaxine by agomelatine in mice are independent of kynurenine pathway
  21. Differential profile of letrozole and exemestane on bone turnover markers in vinylcyclohexene diepoxide treated ovotoxic female mice
  22. Resveratrol suppressed seizures by attenuating IL-1β, IL1-Ra, IL-6, and TNF-α in the hippocampus and cortex of kindled mice
  23. Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment
  24. Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus
  25. Comparative Evaluation of Partial α2-Adrenoceptor Agonist and Pure α2-Adrenoceptor Antagonist on the Behavioural Symptoms of Withdrawal after Chronic Alcohol Administration in Mice
  26. Augmentation of effect of venlafaxine by folic acid in behavioral paradigms of depression in mice: Evidence of serotonergic and pro-inflammatory cytokine pathways
  27. Reduced estradiol synthesis by letrozole, an aromatase inhibitor, is protective against development of pentylenetetrazole-induced kindling in mice
  28. Ameliorative effect of naringin against doxorubicin-induced acute cardiac toxicity in rats
  29. A validated HPLC-UV method and optimization of sample preparation technique for norepinephrine and serotonin in mouse brain
  30. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation
  31. Three Ply-Walled Microcapsules for Enhanced Pharmacokinetics of Poorly Absorbed Risedronate Sodium: Novel Stratagem Toward Osteoporosis
  32. Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice
  33. Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice
  34. Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats
  35. Raloxifene protects against seizures and neurodegeneration in a mouse model mimicking epilepsy in postmenopausal woman
  36. Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-β3 content in bone of female mice
  37. Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice
  38. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery:in vitrocharacterization andin vivoefficacy in epilepsy
  39. Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice
  40. Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model
  41. Comparative Effect of Antihypertensive Therapy on Blood Glucose Level in Hypertensive Patients in an Indian Population
  42. Effect of escitalopram on cardiomyopathy-induced anxiety in mice
  43. Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and creb pathway
  44. Combination Therapy of Piperine and Phenytoin in Maximal Electroshock Induced Seizures in Mice: Isobolographic and Biochemical Analysis
  45. Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice
  46. Histamine H3receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives
  47. Effect of medroxyprogesterone on development of pentylenetetrazole-induced kindling in mice
  48. Pharmacological and Biochemical Analysis of Interactions between N‐Acetylcysteine and Some Antiepileptic Drugs on Experimental Seizures in Mice
  49. Antiepileptic drugs prescription utilization behavior and direct costs of treatment in a national hospital of India
  50. Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse
  51. Bisphosphonates in phenytoin-induced bone disorder
  52. Effect of alprazolam on anxiety and cardiomyopathy induced by doxorubicin in mice
  53. Effect of amiloride: An Na + / H + exchange inhibitor in the middle cerebral artery occlusion model of focal cerebral ischemia in rats
  54. Comparison of antinociceptive and antidiabetic effects of sertraline and amitriptyline on streptozotocin-induced diabetic rats
  55. Insights into the novel three ‘D's of epilepsy treatment: drugs, delivery systems and devices
  56. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies
  57. Beneficial interaction between clobenpropit and pyridoxine in prevention of electroshock-induced seizures in mice: Lack of histaminergic mechanisms
  58. Recent advances in adjunctive therapy for epilepsy: Focus on sodium channel blockers as third-generation antiepileptic drugs
  59. Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic method†
  60. Insights into liaison between antiepileptic drugs and bone
  61. CNS Drug Delivery Systems: Novel Approaches
  62. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers
  63. Seizures and Sodium Hydrogen Exchangers: Potential of Sodium Hydrogen Exchanger Inhibitors as Novel Anticonvulsants
  64. Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model of focal cerebral ischemia in rats
  65. Thioperamide reduces intracellular calcium in mouse brain synaptosomes
  66. Comparative efficacy of liposome-entrapped amiloride and free amiloride in animal models of seizures and serum potassium in mice
  67. Effects of sparfloxacin on CNS functions and urinary hydroxyproline in mice
  68. Modulation of pentylenetetrazole-induced seizures and oxidative stress parameters by sodium valproate in the absence and presence of N-acetylcysteine
  69. Antipsychotic‐like profile of thioperamide, a selective H3‐receptor antagonist in mice
  70. Facilitation Action of N-Acetylcysteine on the Anticonvulsant Effect of Sodium Valproate in Mice
  71. Amiloride protects against pentylenetetrazole-induced kindling in mice
  72. Histamine as an Anticonvulsant Inhibitory Neurotransmitter
  73. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior
  74. Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy
  75. Protection from phenytoin-induced cognitive deficit by Bacopa monniera, a reputed Indian nootropic plant